Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLVS

Clovis Oncology (CLVS) Stock Price, News & Analysis

Clovis Oncology logo

About Clovis Oncology Stock (NASDAQ:CLVS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.08
$1.09
52-Week Range
N/A
Volume
1.16 million shs
Average Volume
8.88 million shs
Market Capitalization
$11.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clovis Oncology and its competitors with MarketBeat's FREE daily newsletter.

CLVS Stock News Headlines

Clovis Chamber names new Retail Rockstar
But this $20 American company could control the secret
The "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMOLISHED Google's record using pure light particles instead of exotic superconductors. The secret? A revolutionary material that ONE American company is the first to commercially produce.
Cancer Horoscope
See More Headlines

CLVS Stock Analysis - Frequently Asked Questions

Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings results on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.48) by $0.08. The biopharmaceutical company earned $37.92 million during the quarter, compared to the consensus estimate of $38.73 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clovis Oncology investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Bristol Myers Squibb (BMY), NIO (NIO) and Micron Technology (MU).

Company Calendar

Last Earnings
11/03/2021
Today
8/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CLVS
CIK
1466301
Employees
N/A
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($1.83)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$264.52 million
Net Margins
-189.37%
Pretax Margin
-189.68%
Return on Equity
N/A
Return on Assets
-57.78%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.14
Quick Ratio
0.12

Sales & Book Value

Annual Sales
$148.76 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.15) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
144,955,000
Free Float
138,577,000
Market Cap
$11.60 million
Optionable
Optionable
Beta
0.24

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CLVS) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners